caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1902008527

Hava LadinskyMD

Allergy/ ImmunologyWestminster, MDI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

REFERRAL NETWORK

Where Hava Ladinsky's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
LAVIETES, WILLIAM56320
Prasad Nataraj
Allergy/ Immunology · Bel Air, MD
3883
Quest Diagnostics Incorporated Md
Clinical Laboratory · Baltimore, MD
28117
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
2252
SINAI HOSPITAL OF BALTIMORE, INC.1569
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,031
Unique beneficiaries
—
Total services
18,270
Distinct HCPCS
14
Medicare payment
$215K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 82 Allergy/ Immunology providers in MD — top quintile (cohort median 3,280).
PRESCRIBING · PART D · 2024
Total Rx claims
1,064
Beneficiaries
—
Total drug cost
$342K
Distinct drugs
21
Brand share
30.0%
Top prescribed drugs
Desloratadine131 claims
Levocetirizine Dihydrochloride122 claims
Montelukast Sodium120 claims
Fluticasone Propionate89 claims
Ipratropium Bromide81 claims
QUALITY · MIPS · 2024
Final MIPS score
75.0
Quality
0.0
Cost
0.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
0.00%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$90
Payment records
4
By payment type
Food and Beverage$90